The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N1-(4-(1,5,9-triazacyclododecan-1-yl)butyl)butane-1,4-diamine ID: ALA5084961
PubChem CID: 166635235
Max Phase: Preclinical
Molecular Formula: C17H44Cl5N5
Molecular Weight: 313.53
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cl.Cl.Cl.Cl.Cl.NCCCCNCCCCN1CCCNCCCNCCC1
Standard InChI: InChI=1S/C17H39N5.5ClH/c18-8-1-2-9-19-10-3-4-15-22-16-6-13-20-11-5-12-21-14-7-17-22;;;;;/h19-21H,1-18H2;5*1H
Standard InChI Key: CSTKMKJDQDFPNF-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 22 0 0 0 0 0 0 0 0999 V2000
26.1835 -1.0000 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.3084 -5.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0230 -4.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5939 -4.7167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7374 -5.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4519 -4.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1664 -5.1292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.8808 -4.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5953 -5.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3098 -4.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0242 -5.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7387 -4.7167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.4485 -5.1301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7322 -3.8918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4508 -3.4811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8845 -2.6660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1715 -2.2489 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.4515 -2.6573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1631 -4.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8701 -5.1283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5811 -4.7198 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5805 -3.8992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8690 -3.4871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9002 -1.4083 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.1210 -3.9083 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
26.0877 -6.2500 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
28.9960 -6.1583 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 1 0
3 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 1 0
13 19 1 0
15 14 1 0
15 18 1 0
23 16 1 0
16 17 1 0
17 18 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 313.53Molecular Weight (Monoisotopic): 313.3205AlogP: 0.76#Rotatable Bonds: 9Polar Surface Area: 65.35Molecular Species: BASEHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 11.01CX LogP: -0.54CX LogD: -10.08Aromatic Rings: ┄Heavy Atoms: 22QED Weighted: 0.47Np Likeness Score: -0.32
References 1. Dobrovolskaite A, Gardner RA, Delcros JG, Phanstiel O.. (2022) Development of Polyamine Lassos as Polyamine Transport Inhibitors., 13 (2.0): [PMID:35178189 ] [10.1021/acsmedchemlett.1c00557 ]